7th ESO Arab and Southern European Countries Masterclass in Clinical Oncology
30 ESCO credits
14.12.2018 - 17.12.2018
Limassol, Cyprus
MASTERCLASS
Description
Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs: J. Gligorov, FR - S. Khatib, JO
Host Chair: D. Papamichael, CY
AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical and clinicaloncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast , gynaecological, lung, urologicaland gastrointestinal cancers. Spotlight sessions will facilitate compact update on head and neck, melanoma, elderly patients, soft tissue sarcoma, non-Hodgkin lymphoma.
TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver casepresentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.
THE MASTERCLASS:
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast , gynaecological, lung, urological and gastrointestinal cancers.
Held under the auspices of the | |||
![]() |
![]() |
Faculty
FACULTY
M.S. Aapro, Clinique de Genolier, CH
D. Arnold, Asklepios Tumorzentrum Hamburg, DE
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Azim jr, American University of Beirut, LB
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
G. Ceresoli, Humanitas Gavazzeni, Bergamo, IT
A. Charalambous, Cyprus University of Technology, Limassol, CY
A. Constantinidou, University of Cyprus, Medical School, Nicosia, CY
A. Eggermont, Institut Gustave Roussy, Paris, FR
A. Eniu, Cancer Institute "Ion Chiricuta", Cluj Napoca, RO
R. Gaafar, National Cancer Institute, Cairo, EG
F. Geara, American University of Beirut, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
H. Khaled, National Cancer Institute, Cairo, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, Ioannina School of Medicine, GR
G. Pruneri, National Cancer Institute, Milan, IT
J. Remon-Masip, Hospital Vall'd'Hebron, Barcelona, ES
A. Shamseddine, American University of Beirut, LB
J.B. Vermorken, Antwerp University Hospital, BE
General information
ORGANISING SECRETARIAT
Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464523
Fax: +39 02 85464545
Email: dmengato@eso.net
Applications:
Alice Ciocchini, aciocchini@eso.net, ph +39 02 85464529
IMPORTANT DEADLINES |
||
Application by: | 30 June 2018 | |
---|---|---|
Save event date: | 14 December 2018 |
Application
PARTICIPANT'S PROFILE
• Age up to 40 years
• At least 2-3 years’ experience in medical or clinical oncology
• Involvement in scientific activities
• Intermediate level of English
HOW TO APPLY
Interested oncologists should apply online providing:
• Letter describing motivation for attending;
• Supporting letter from head of department or mentor;
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
• Clinical case (see below)
Priority will be given to suitable applicants working in Arab and Southern European countries.
Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event-dedicated website will be created and all questionnaires and certificates will be accessible only from there. Any potential problems with meeting this request should be communicated to the secretariat as part of the application process.
ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
Successful applicants are granted free registration and accommodation
THE APPLICATION DEADLINE HAS PASSED (12 JULY 2018)
Programme
13 December
Participants’ arrival and dinner |
14 December
7:30 | Registration | |
8:80 | Welcome address M.S. Aapro, CH - N. Pavlidis, GR |
|
BREAST CANCER SESSION Chairs: J. Gligorov, FR - H. Azim, EG |
||
8:30 | What the clinician needs to know from the breast pathologist G. Pruneri, IT |
|
8:55 | Discussion | |
9:00 | Current controversies/challenges in breast surgery M.J. Cardoso, PT |
|
9:25 | Discussion | |
9:30 | The role of radiotherapy in e arly and locally advancedbreast cancer R. Orecchia, IT |
|
9:55 | Discussion | |
10:00 | Coffee Break | |
10:30 | Genomic testing in breast cancer H. Azim jr, LB |
|
10:55 | Discussion | |
11:00 | Neoadjuvant/adjuvant chemotherapy and biological agents A. Eniu, RO |
|
11:25 | Discussion | |
11:30 | Neoadjuvant/adjuvant endocrine therapy J. Gligorov, FR |
|
11:55 | Discussion | |
12:00 | Management of HER2+ advanced breast cancer A. Eniu, RO |
|
12:25 | Discussion | |
12:30 | Management of triple-negative advanced breast cancer H. Azim, EG |
|
12:55 | Discussion | |
13:00 | Management of ER+ advanced breast cancer J. Gligorov, FR |
|
13:25 | Discussion | |
13:30 | Lunch Break |
|
14:30 | Breast Cancer Tumor Board (4 cases) | |
GYNECOLOGICAL CANCERS SESSION Chairs: A. Constantinidou, CY - J.B. Vermorken, BE |
||
15:30 | Systemic management of ovarian cancer J.B. Vermorken, BE |
|
15:55 | Discussion | |
16:00 | Systemic management of locally advanced ormetastatic cervical and endometrial cancer J.B. Vermorken, BE |
|
16:25 | Discussion | |
16:30 | Coffee break | |
17:00 | Gynecological Cancers Tumor Board (4 cases) | |
20:00 | Dinner |
15 December
LUNG CANCER SESSION Chairs: R. Gaafar, EG - F. Geara, LB |
||
8:30 | The impact of radiation therapy in lung cancer F. Geara, LB |
|
8:55 | Discussion |
|
9:00 | Neoadjuvant and adjuvant systemic treatment in NSCLC G. Ceresoli, IT |
|
9:25 | Discussion |
|
9:30 | Systemic chemotherapy and targeted treatment in metastatic NSCLC J. Remon-Masip, ES |
|
9:55 | Discussion |
|
10:00 | Immune check point inhibitors in NSCLC J. Remon-Masip, ES |
|
10:25 | Discussion |
|
10:30 | Coffee Break |
|
11:00 |
Management of advanced small-cell lung cancer R. Gaafar, EG |
|
11:25 |
Discussion |
|
11:30 | Systemic management of advanced mesothelioma G. Ceresoli, IT |
|
11:55 | Discussion |
|
12:00 | Lung Cancer Tumor Board (4 cases) |
|
13:00 | Lunch Break |
|
SPOTLIGHT SESSION 1 |
||
14:00 | Modern management of melanoma A. Eggermont, FR |
|
14:25 | Discussion |
|
14:30 | Update in the management of head and neck cancer J.B. Vermorken, BE |
|
14:55 | Discussion | |
15:00 | How do I manage cancer in elderly patients M.S. Aapro, CH |
|
15:25 | Discussion |
|
15:30 | The role of informal supporter A. Charalambous, CY |
|
15:50 | Discussion | |
15:30 | Coffee Break |
|
16:00 |
Parallel Group Sessions I (Cases discussion in three Groups) |
16 December
UROLOGICAL CANCERS SESSION Chairs: H. Khaled, EG - N. Mottet, FR |
||
8:30 | Management including active surveillance of localized prostate cancer J. Khader, JO |
|
8:55 | Discussion |
|
9:05 | Key topics in locally advanced, advanced and metastatic prostate cancer N. Mottet, FR |
|
9:45 | Discussion |
|
10:00 | Update in the management of bladder cancer H. Khaled, EG |
|
10:25 | Discussion |
|
10:30 | Coffee Break |
|
11:00 | Update in the management of renal cancer N. Mottet, FR |
|
11:25 | Discussion |
|
11:30 | Management of relapsed testicular cancer A. Shamseddine, LB |
|
12:00 | Urological Cancers Tumor Board (4 cases) |
|
13:00 | Lunch Break |
|
SPOTLIGHT SESSION 2 | ||
14:00 | Cancer of unknown primary N. Pavlidis, GR |
|
14:25 | Discussion |
|
14:30 | Supportive care M.S. Aapro, CH |
|
14:55 | Discussion |
|
15:00 | Update in the management of soft tissue sarcomas A. Constantinidou, CY |
|
15:25 | Discussion |
|
15:30 | Coffee Break |
|
16:00 | Parallel Group Sessions II (Cases discussion in three Groups) |
|
20:00 | Dinner |
17 December
GASTROINTESTINAL CANCERS SESSION Chairs: D. Papamichael, CY - D. Arnold, DE |
||
8:30 | Adjuvant / neoadjuvant systemic treatment in colorectal cancer D. Papamichael, CY |
|
8:55 | Discussion |
|
9:00 | Systemic treatment in advanced colon cancer D. Arnold, DE |
|
9:25 | Discussion |
|
9:30 | Radiation treatment in rectal cancer J. Khader, JO |
|
9:55 | Discussion |
|
10:00 | Systemic treatment in early and advanced gastric cancer D. Arnold, DE |
|
10:25 | Discussion |
|
10:30 | Coffee break |
|
11:00 | Gastrointestinal Cancers Tumor Board (4 cases) |
|
12:00 | Learning Self-Assessment Test |
|
13:15 | Closing remarks |